Once a blood clot breaks free from a leg vein, it can reach the lungs in a matter of seconds. Venous blood flows from the legs toward the heart at a pace that carries a dislodged fragment through the inferior vena cava, into the right side of the heart, and out into the pulmonary arteries remarkably quickly. The real story, though, is not the transit speed itself but the chain of events that leads up to it, why some clots travel and others do not, and what determines survival once a clot lodges in the lung.
The Route a Clot Takes
A clot that forms in one of the deep veins of the calf or thigh sits inside a low-pressure, one-directional pipeline. Venous blood in the legs moves upward, helped along by one-way valves and the squeezing action of surrounding muscles. Deep vein clots commonly start in the smaller veins of the calf, particularly the soleal veins inside the calf muscle, and can grow toward larger, more proximal veins over days or weeks as layers of fibrin and platelets accumulate.1J-STAGE / Annals of Vascular Diseases. Pathophysiology of Venous Thromboembolism with Respect to the Anatomical Features of the Deep Veins of Lower Limbs: A Review When a piece breaks off, it enters the venous bloodstream and travels upward through increasingly larger veins: the popliteal vein behind the knee, the femoral vein in the thigh, and the iliac vein in the pelvis, all merging into the inferior vena cava.
From the inferior vena cava, the clot enters the right atrium of the heart, passes through the tricuspid valve into the right ventricle, and is then pumped directly into the pulmonary arteries. The total distance from a deep calf vein to the lungs is roughly a meter to a meter and a half. Blood velocity in large veins is typically in the range of 10 to 40 centimeters per second, though it fluctuates with breathing, posture, and activity. At those speeds, a free-floating clot fragment can complete the entire journey in under a minute. In many cases, the transit from detachment to lung lodgment happens so fast that there is no warning interval at all.
What Makes a Clot Break Free
If clots can reach the lungs in seconds, the more consequential question is what causes them to detach in the first place. This turns out to be less well understood than you might expect. A common assumption is that the shearing force of blood flowing past a clot gradually erodes it until a piece snaps off. Recent work, however, suggests that shear stress alone is unlikely to be the main culprit. A computational analysis found that even severely elevated shear stress appears insufficient to dislodge a clot. Instead, forces generated by the stretching of the vein wall and, in clots that fully block a vein, the pressure of blood pushing against the obstruction seem to be more critical factors in causing embolization.2PubMed. “What makes blood clots break off?” A Back-of-the-Envelope Computation Toward Explaining Clot Embolization
This matters because it shifts how we think about risk. Activities that change the pressure inside veins or cause the vein wall to stretch suddenly, like straining, standing up after prolonged immobility, or even deep breathing, could be more relevant to embolization than the steady flow of blood past a clot. The science here is still evolving, and computational models of how clots detach are an active area of research.3Scientific Reports. Clot embolization studies and computational framework for embolization in a canonical tube model But the emerging picture is that embolization is more of a mechanical event driven by wall dynamics than a slow erosion driven by blood flow.
Which Clots Are Most Dangerous
Not all deep vein clots carry the same risk of traveling to the lungs. The single biggest factor is location. Clots that sit in the proximal veins, meaning the popliteal vein and above, are substantially more likely to cause pulmonary embolism than clots confined to the small veins of the calf.4PubMed Central. A Comprehensive Literature Review on the Management of Distal Deep Vein Thrombosis Isolated distal deep vein thrombosis is generally considered more benign and is sometimes managed differently, with closer monitoring rather than immediate aggressive treatment.5PubMed Central. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study
The reason proximal clots are riskier is partly about size. A clot in the femoral or iliac vein has access to a wider channel and can release larger fragments that are big enough to block significant pulmonary arteries. But the picture is not perfectly clean. One systematic study found no clear difference in the degree of proximal extension between patients with deep vein thrombosis who did and did not develop pulmonary embolism.6PubMed. Deep venous thrombosis and the risk of pulmonary embolism. A systematic study So while proximal location is a strong risk marker, it is not a guarantee. Some distal clots do embolize, and some proximal clots never do.
How long a clot has been growing also plays a role. Clot maturation happens in stages. In the first week after formation, clots consist primarily of platelet plugs and fibrin layers, with no significant response from the surrounding vessel wall.7PubMed Central. State-of-Art in the Age Determination of Venous Thromboembolism: A Systematic Review Over subsequent weeks, the clot becomes more organized, with inflammatory cells infiltrating and eventually scar-like tissue replacing the original structure. Fresh clots tend to be softer and less adherent to the vein wall, making them potentially more prone to breaking loose. Older, organized clots are generally more firmly attached, though they can still embolize.
What Happens When the Clot Reaches the Lung
When a clot fragment arrives in the pulmonary arteries, it lodges wherever the vessel becomes too narrow for it to pass. The result is a pulmonary embolism. Small clots may park in distal branches of the pulmonary tree and cause relatively minor symptoms or none at all. Larger clots can block major branches, and the largest can straddle the main pulmonary artery bifurcation, a configuration known as a saddle embolism.
You might assume that a saddle embolism, because it sits at the widest part of the pulmonary artery tree, is automatically the most dangerous form. But the evidence complicates that assumption. In one study comparing saddle and non-saddle pulmonary embolism in patients who already had right ventricular dysfunction, the non-saddle group actually showed more clinical signs of severe right heart failure, needed more aggressive interventions, and had numerically higher mortality, though the difference was not statistically significant.8PubMed. Dispelling the Saddle Pulmonary Embolism Myth (from a Comparison of Saddle Versus Non-Saddle Pulmonary Embolism) The takeaway is that the position of the clot alone does not tell you how severe the situation is. What matters more is how much of the pulmonary vasculature is blocked overall and how much strain that puts on the right side of the heart.
Right heart strain is the main killer in pulmonary embolism. When clot burden is high enough to significantly obstruct blood flow through the lungs, pressure in the pulmonary arteries rises sharply, and the right ventricle, which is not built for high-pressure work, begins to fail. In a study of saddle pulmonary embolism patients, about two-thirds showed right heart strain on echocardiography, with average pulmonary artery pressures around 46 mmHg, well above normal.9PubMed Central. Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes
When the Clot Stalls in the Heart
Most clots pass through the right side of the heart so quickly that they are never seen there. But in a small number of cases, a clot gets temporarily trapped in the right atrium or right ventricle. These right heart thrombi are visible on echocardiography and represent one of the more dangerous situations in pulmonary embolism.
In a large analysis of over 12,000 pulmonary embolism patients with echocardiographic data, about 2.6% had a visible clot in the right heart. Those patients were roughly two and a half times more likely to die from any cause, and over four times more likely to die specifically from pulmonary embolism, compared with patients whose clots had already passed through to the lungs.10European Respiratory Journal. Right heart thrombi in pulmonary embolism A clot large enough to be seen sitting in the heart chamber is, understandably, at high risk of causing massive further embolization if it shifts.
In the saddle PE study, a clot visible in the right heart was found in about 8% of those patients, and over a third of them died in the hospital.9PubMed Central. Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes The association between a visualized right heart thrombus and inpatient death was statistically significant. These findings underscore why imaging the heart in pulmonary embolism patients carries real prognostic value.
Why Treatment Timing Matters
Because transit from leg to lung can happen in seconds, the relevant time window for intervention is not about intercepting the clot mid-journey. By the time someone has symptoms of pulmonary embolism, the clot is already there. The urgency is about how fast treatment starts once the clot has lodged.
For the majority of pulmonary embolism cases, the first-line treatment is anticoagulation, medication that prevents the clot from growing and gives the body’s own clot-dissolving systems time to work. In hospitals with pulmonary embolism response teams, anticoagulation is initiated extremely quickly, averaging just a couple of minutes from the decision to treat.11PubMed. Evaluating time to treatment and in-hospital outcomes of pulmonary embolism response teams The vast majority of patients, over 90% in that analysis, are managed with anticoagulation alone.
For the sickest patients, those with hemodynamic collapse from massive clot burden, systemic thrombolysis (clot-busting drugs delivered intravenously) or catheter-directed therapy may be needed. Here, time becomes critical in a different way. One study found that the optimal window for systemic thrombolysis in high-risk pulmonary embolism was within about 8.5 hours of symptom onset. Patients treated after that threshold had dramatically higher 30-day cardiovascular mortality.12PubMed. Systemic thrombolysis in haemodynamically unstable pulmonary embolism: The earlier the better? Another analysis found that while thrombolysis could still offer benefit beyond 8 hours, its effectiveness dropped significantly after 24 hours from symptom onset.13PubMed. The prognostic value of time from symptom onset to thrombolysis in patients with pulmonary embolism
The practical message: if you develop sudden shortness of breath, chest pain, rapid heart rate, or lightheadedness, especially if you have known risk factors for deep vein thrombosis, seek emergency care immediately. The clot’s journey is already over. What determines outcome now is how quickly treatment begins.
The Diagnostic Challenge
One of the frustrating aspects of this condition is that finding the source clot in the leg does not always help diagnose pulmonary embolism. You might expect that an ultrasound of the leg veins would be a reliable way to confirm whether a clot has traveled to the lungs, but the sensitivity is surprisingly low. In patients with confirmed pulmonary embolism, compression ultrasonography of the leg detected deep vein thrombosis in only about 29% of cases.14PubMed. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism
This makes sense when you think about the mechanics. If a clot has fully detached and traveled to the lungs, there may be nothing left in the leg vein to find. Or the remaining clot may be too small or too distal for standard compression ultrasound to detect reliably. The gold standard for diagnosing pulmonary embolism is CT pulmonary angiography, a contrast-enhanced scan of the chest that directly visualizes clot in the pulmonary arteries. Leg ultrasound can be a useful supplement, and when it is positive it helps confirm the diagnosis, but a negative leg ultrasound does not rule out pulmonary embolism.
When a Leg Clot Travels to the Brain Instead
In rare cases, a clot from the leg bypasses the lungs entirely and ends up in the arterial circulation, causing a stroke or other organ damage. This is called paradoxical embolism, and it happens through a structural heart defect known as a patent foramen ovale, a small opening between the right and left atria that persists from fetal development. About a quarter of the general population has a patent foramen ovale, though most never know it and it causes no problems.15PubMed Central. An Unusual Location of Deep Venous Thrombosis Associated with Ischemic Stroke and Persistent Foramen Ovale
When a clot enters the right atrium, it normally gets swept into the right ventricle and out to the lungs. But if a patent foramen ovale is present and right-sided heart pressure temporarily exceeds left-sided pressure, which can happen during a cough, straining, or other Valsalva maneuver, the clot can cross through the opening into the left atrium. From there, it enters the left ventricle and gets pumped out into the aorta and systemic arteries, where it can lodge in the brain, kidneys, or elsewhere.16PubMed Central. Patent Foramen Ovale and Stroke–Current Status The prevalence of patent foramen ovale is roughly twice as high among young stroke patients as in the general population, which is part of the epidemiological evidence linking the two.15PubMed Central. An Unusual Location of Deep Venous Thrombosis Associated with Ischemic Stroke and Persistent Foramen Ovale There have even been documented cases where a clot was literally caught mid-transit across the foramen ovale on echocardiography.
Paradoxical embolism remains relatively uncommon, but it is an important reminder that the consequences of a deep vein thrombosis extend beyond pulmonary embolism. In young patients who have a stroke without obvious cardiovascular risk factors, investigation for a patent foramen ovale and concurrent deep vein thrombosis is part of the standard workup.
IVC Filters and Physically Blocking the Path
For patients at high risk of pulmonary embolism who cannot take anticoagulation, such as those with active bleeding or upcoming surgery, one option is to place a mechanical barrier directly in the pathway. Inferior vena cava filters are small metal devices inserted into the IVC, typically below the level where the renal veins enter, designed to catch clot fragments traveling upward from the legs before they reach the heart and lungs.17PubMed. A resolved two-way coupled CFD/6-DOF approach for predicting embolus transport and the embolus-trapping efficiency of IVC filters
The concept is straightforward: if you cannot prevent the clot from forming or dissolve it chemically, put a physical net in its path. In practice, IVC filters have a complicated track record. They do reduce the short-term risk of pulmonary embolism, but they also carry their own complications, including filter migration, fracture of the filter struts, and clot forming on the filter itself. Modern retrievable filters are designed to be removed once the period of highest risk has passed, but retrieval rates in real-world practice have historically been lower than ideal, leaving many patients with a permanent device they no longer need. The decision to place one involves weighing immediate PE risk against long-term device complications, and guidelines generally reserve them for patients who truly cannot receive anticoagulation.
How Clots Form in Bedridden Patients
The reason immobility is such a prominent risk factor for deep vein thrombosis connects directly to the anatomy of the calf veins. The deep veins inside the calf muscles, especially the soleal veins, depend heavily on the muscular pumping action of walking and moving to keep blood flowing. When a patient is bedridden, that pump essentially shuts off. The soleal veins, which have a wider, more pouch-like structure compared with other calf veins, become particularly vulnerable to stagnant blood pooling and clot formation.1J-STAGE / Annals of Vascular Diseases. Pathophysiology of Venous Thromboembolism with Respect to the Anatomical Features of the Deep Veins of Lower Limbs: A Review
By contrast, the three main crural veins (the posterior tibial, anterior tibial, and peroneal veins) benefit from the pulsation of the arteries that run alongside them, which provides some passive blood movement even during rest. This anatomical difference helps explain why clots in immobile patients tend to start in the intramuscular veins rather than the paired crural veins. It also explains why early mobilization after surgery and the use of compression devices on the calves are standard measures in hospital settings: they substitute for the muscular pump that bedridden patients cannot use themselves.